Clinical Trial Update: Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 basket study evaluating simlukafusp alfa in combination therapy for advanced/metastatic solid tumors; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Head and Neck Cancer
• Oesophageal Cancer

Drugs mentioned

• Simlukafusp alfa (simlukafusp alfa)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers | Phase 2 | Status: TERMINATED | Results posted: 2023-02-21